BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 03/08/2023

FDA Announces Draft Guidance for Industry on Fixed-Combinations and Single-Entity Antiretrovirals for HIV-1 Treatment and Prevention

The FDA is releasing a draft guidance for industry on single-entity antiretroviral and fixed-combination drug products for HIV-1 treatment and prevention, intended for procurement under PEPFAR, replacing a 2006 guidance.

Source: Federal Register — Food and Drug AdministrationOpen original release →